A detailed history of Albion Financial Group transactions in Organon & Co. stock. As of the latest transaction made, Albion Financial Group holds 100 shares of OGN stock, worth $1,574. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$1,574
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 25, 2023

SELL
$19.27 - $24.63 $635 - $812
-33 Reduced 24.81%
100 $2,000
Q1 2023

Apr 18, 2023

SELL
$21.42 - $32.08 $642 - $962
-30 Reduced 18.4%
133 $3,000
Q4 2022

Feb 03, 2023

BUY
$23.31 - $28.61 $699 - $858
30 Added 22.56%
163 $4,000
Q3 2022

Oct 27, 2022

SELL
$23.4 - $34.25 $163 - $239
-7 Reduced 5.0%
133 $3,000
Q1 2022

May 09, 2022

SELL
$30.45 - $39.36 $213 - $275
-7 Reduced 4.76%
140 $5,000
Q4 2021

Feb 15, 2022

BUY
$28.67 - $37.13 $401 - $519
14 Added 10.53%
147 $4,000
Q2 2021

Aug 12, 2021

BUY
$28.45 - $38.0 $3,783 - $5,054
133 New
133 $4,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Albion Financial Group Portfolio

Follow Albion Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Albion Financial Group , based on Form 13F filings with the SEC.

News

Stay updated on Albion Financial Group with notifications on news.